Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Bazira, Joel ^a   Asiimwe, Benon B ^b   Joloba, Moses L ^b   Bwanga, Freddie ^b   Matee, Mecky I ^c  

^a MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^b MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANALYZER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENE MUTATION; GENETIC DATABASE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INHA GENE; KATG GENE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLESIOMORPHY; PROMOTER REGION; RETREATMENT; RPOB GENE; TUBERCULOSIS; UGANDA; WILD TYPE; CLASSIFICATION; DRUG EFFECT; GENETICS; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR TYPING;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; GENETIC VARIATION; GENOTYPE; HIV INFECTIONS; HUMANS; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TUBERCULOSIS; UGANDA;

EID: 79953181322     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-81     Document Type: Article

References (60)

1. WHO, Report Global tuberculosis control - epidemiology, strategy, financing. WHO/HTM/TB/2009.411 2009, WHO, Report.
2. Republic of Uganda, Ministry of Health National tuberculosis and Leprosy programme South Western Uganda Annual report. 2005, Republic of Uganda, Ministry of Health.
3. Republic of Uganda, Ministry of Health National tuberculosis and Leprosy programmeSouth Western Uganda Annual report. 2008, Republic of Uganda, Ministry of Health.
4. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, Nicol M, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2006, 103(8):2869-73. 10.1073/pnas.0511240103, 1413851, 16477032.
5. Filliol I, Motiwala AS, Cavatore M, Qi W, Hernando Hazbon M, et al. Global Phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J Bacteriol 2006, 188:759-772. 10.1128/JB.188.2.759-772.2006, 1347298, 16385065.
6. Bucher HC, Griffith LE, Guyatt GH, Sudre P, Naef M, Sendi P, Battegay M. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS 1999, 13(4):501-7. 10.1097/00002030-199903110-00009, 10197379.
7. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR, Hopewell PC. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992, 326(4):231-5. 10.1056/NEJM199201233260404, 1345800.
8. Odhiambo JA, Borgdorff MW, Kiambih FM, Kibuga DK, Kwamanga DO, Ng'ang'a L, et al. Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986-1996. Am J Public Health 1999, 89(7):1078-82. 10.2105/AJPH.89.7.1078, 1508825, 10394319.
9. Puustinen K, Marjamaki M, Rastogi N, Sola C, Filliol I, Ruutu P, Holmstrom P, Viljanen MK, Soini H. Characterization of Finnish Mycobacterium tuberculosis isolates by spoligotyping. J Clin Microbiol 2003, 41(4):1525-8. 10.1128/JCM.41.4.1525-1528.2003, 153930, 12682140.
10. van Crevel R, Nelwan RH, de Lenne W, Veeraragu Y, van der Zanden AG, Amin Z, van der Meer JW, van Soolingen D. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis 2001, 7:880-3. 10.3201/eid0705.010518, 2631862, 11747703.
11. Brosch R, Gordon VS, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K, Garnier T, Gutierrez C, Hewinson G, Kremer K, Parsons ML, Pym SA, Samper S, van Soolingen D, Cole TS. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 2002, 99(6):3684-9. 10.1073/pnas.052548299, 122584, 11891304.
12. Brosch R, Pym AS, Gordon SV, Cole ST. The evolution of mycobacterial pathogenicity: clues from comparative genomics. Trends Microbiol 2001, 9(9):452-8. 10.1016/S0966-842X(01)02131-X, 11553458.
13. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Barrell BG, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393(6685):537-44. 10.1038/31159, 9634230.
14. Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane, Small PM. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999, 284(5419):1520-3. 10.1126/science.284.5419.1520, 10348738.
15. Gordon SV, Brosch R, Billault A, Garnier T, Eiglmeier K, Cole ST. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 1999, 32(3):643-55. 10.1046/j.1365-2958.1999.01383.x, 10320585.
16. Kremer K, van Soolingen D, Frothingham R, Haas WH, Hermans PWM, Martín C, Palittapongarnpim P, Plikaytis BB, Riley LW, Yakrus MA, Musser JM, van Embden JDA. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol 1999, 37(8):2607-18. 85295, 10405410.
17. Mojica FJ, F C, Juez G, Rodriguez-Valera F. Long stretches of short tandem repeats are present in the largest replicons of the Archaea Haloferax mediterranei and Haloferax volcanii and could be involved in replicon partitioning. Mol Microbiol 1995, 17:85-93. 10.1111/j.1365-2958.1995.mmi_17010085.x, 7476211.
18. Jansen R, E J, Gaastra W, Schouls LM. Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol 2002, 43:1565-1575. 10.1046/j.1365-2958.2002.02839.x, 11952905.
19. Pourcel C, S G, Vergnaud G. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 2005, 151:653-663. 10.1099/mic.0.27437-0, 15758212.
20. Bolotin A, Q B, Renault P, Sorokin A, Ehrlich SD, Kulakauskas S, Lapidus A, Goltsman E, Mazur M, Pusch GD, et al. Complete sequence and comparative genome analysis of the dairy bacterium Streptococcus thermophilus. Nat Biotechnol 2004, 22:1554-1558. 10.1038/nbt1034, 15543133.
21. Jansen R, v EJ, Gaastra W, Schouls LM. Identification of a novel family of sequence repeats among prokaryotes. Genomics 2002, 6(1):23-33.
22. van Embden JD, van Gorkom T, Kremer K, Jansen R, van Der Zeijst BA, Schouls LM. Genetic variation and evolutionary origin of the direct repeat locus of Mycobacterium tuberculosis complex bacteria. J Bacteriol 2000, 182(9):2393-401. 10.1128/JB.182.9.2393-2401.2000, 111299, 10762237.
23. Makinen J, M H, Marjamaki M, Viljanen MK, Soini H. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006, 44(2):350-352. 10.1128/JCM.44.2.350-352.2006, 1392655, 16455882.
24. Miotto P, P F, Cirillo DM, Migliori GB. Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2008, 46(1):393-394. 10.1128/JCM.01066-07, 2224251, 17977988.
25. Barnard M, A H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008, 177(7):787-792. 10.1164/rccm.200709-1436OC, 18202343.
26. Kent P, Kubica G. Public health mycobacteriology: A guide for the level III laboratory. U. S. department of Health and Human Services. Centres for Disease Control, Atlanta, Ga. 1985, Centres for Disease Control, Atlanta, Ga.
27. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993, 31(2):406-9. 262774, 8381814.
28. Huard RC, Lazzarini LC, Butler WR, van Soolingen D, Ho JL. PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions. J Clin Microbiol 2003, 41(4):1637-50. 10.1128/JCM.41.4.1637-1650.2003, 153936, 12682155.
29. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997, 35(4):907-14. 229700, 9157152.
30. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA, Allix C, Aristimuno L, Arora J, Baumanis V, Binder L, Cafrune P, Cataldi A, et al. "Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology.". BMC Microbiol 6:23.
31. Allix-Béguec C, H D, Weniger T, Supply P, Niemann S. "Evaluation and user-strategy of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates.". J Clin Microbiol 2008, 46(8):2692-9. 10.1128/JCM.00540-08, 2519508, 18550737.
32. Republic of Uganda, Ministry. of. Health Manual of the National Tuberculosis and Leprosy programme in Uganda for district TB/Leprosy supervisors: First edition. 1992, Republic of Uganda, Ministry. of. Health.
33. Laboratory services in tuberculosis control. Part 2. Microscopy. WHO document WHO/TB/98.258. Geneva
34. Byarugaba F, E E, Godreuil S, Grimaud P. Pulmonary tuberculosis and Mycobacterium bovis, Uganda. Emerg Infect Dis 2009, 15(1).
35. Asiimwe BB, Ghebremichael S, Kallenius G, Koivula T, Joloba ML. Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban Kampala, Uganda. BMC Infect Dis 2008, 8:101. 10.1186/1471-2334-8-101, 2519071, 18662405.
36. Niemann S, Rüsch-Gerdes S, Joloba LM, Whalen CC, Guwatudde D, Ellner JJ, Eisenach K, Fumokong N, Johnson LJ, Aisu T, Mugerwa DR, Okwera A, Schwander KS. Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. J Clin Microbiol 2002, 40(9):3398-405. 10.1128/JCM.40.9.3398-3405.2002, 130701, 12202584.
37. Niemann S, Kubica T, Bange FC, Adjei O, Browne EN, Chinbuah MA, Diel R, Gyapong J, Horstmann RD, Joloba ML, Meyer CG, Mugerwa RD, Okwera A, Osei I, Owusu-Darbo E, Schwander SK, Rusch-Gerdes S. The species Mycobacterium africanum in the light of new molecular markers. J Clin Microbiol 2004, 42(9):3958-62. 10.1128/JCM.42.9.3958-3962.2004, 516319, 15364975.
38. Asiimwe BB, Koivula T, Kallenius G, Huard RC, Ghebremichael S, Asiimwe J, Joloba ML. Mycobacterium tuberculosis Uganda genotype is the predominant cause of TB in Kampala, Uganda. Int J Tuberc Lung Dis 2008, 12(4):386-91.
39. Githui WA, Jordaan AM, Juma ES, Kinyanjui P, Karimi FG, Kimwomi J, Meme H, Mumbi P, Streicher EM, Warren R, van Helden PD, Victor TC. Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, Kenya. Int J Tuberc Lung Dis 2004, 8(3):352-60.
40. Kibiki GS, Mulder B, Dolmans WM, de Beer JL, Boeree M, Sam N, van Soolingen D, Sola C, van der Zanden AG. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania. BMC Microbiol 2007, 7:51. 10.1186/1471-2180-7-51, 1913919, 17540031.
41. Kallenius G, Koivula T, Ghebremichael S, Hoffner SE, Norberg R, Svensson E, Dias F, Marklund BI, Svenson SB. Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau. J Clin Microbiol 1999, 37(12):3872-8. 85833, 10565899.
42. Niobe-Eyangoh SN, Kuaban C, Sorlin P, Thonnon J, Vincent V, Gutierrez MC. Molecular characteristics of strains of the cameroon family, the major group of Mycobacterium tuberculosis in a country with a high prevalence of tuberculosis. J Clin Microbiol 2004, 42(11):5029-35. 10.1128/JCM.42.11.5029-5035.2004, 525220, 15528691.
43. Easterbrook PJ, Gibson A, Murad S, Lamprecht D, Ives N, Ferguson A, Lowe O, Mason P, Ndudzo A, Taziwa A, Makombe R, Mbengeranwa L, Sola C, Rastogi N, Drobniewski F. High rates of clustering of strains causing tuberculosis in Harare, Zimbabwe: a molecular epidemiological study. J Clin Microbiol 2004, 42(10):4536-44. 10.1128/JCM.42.10.4536-4544.2004, 522374, 15472306.
44. Chihota V, Apers L, Mungofa S, Kasongo W, Nyoni IM, Tembwe R, Mbulo G, Tembo M, Streicher EM, van der Spuy GD, Victor TC, van Helden P, Warren RM. Predominance of a single genotype of Mycobacterium tuberculosis in regions of Southern Africa. Int J Tuberc Lung Dis 2007, 11(3):311-8.
45. Gagneux S, Small PM. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 2007, 7(5):328-37. 10.1016/S1473-3099(07)70108-1, 17448936.
46. Eldholm V, Matee M, Mfinanga SG, Heun M, Dahle UR. A first insight into the genetic diversity of Mycobacterium tuberculosis in Dar es Salaam, Tanzania, assessed by spoligotyping. BMC Microbiol 2006, 6:76. 10.1186/1471-2180-6-76, 1592105, 16970826.
47. Bretzel G, A M, Wendl-Richter U, Adatu F, Aisu T, van Wijnen A, Sticht-Groh V. Anti-tuberculosis drug resistance surveillance in Uganda 1996-1997. nt J Tuberc Lung Dis 1999, 3(9):810-815.
48. Umubyeyi AN, V G, Gasana M, Basinga P, Zawadi JP, Gatabazi J, Pauwels P, Nzabintwali F, Nyiramasarabwe L, Fissette K, Rigouts L, Struelens MJ, Portaels F. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda. Int J Tuberc Lung Dis 2007, 11(2):189-194.
49. Murray J. The white plague: down and out, or up and coming?. Am Rev Respir Dis 1989, 140:1788-1795.
50. Shemyakin IG, Stepanshina NV, Ivanov YI, Lipin YM, Anisimova AV, Onasenko GA, Korobova VO, Shinnick MT. Characterization of drug-resistant clinical isolates of Mycobacterium tuberculosis derived from Russian inmates. Int J Tuberc Lung Dis 2004, 8:1194-1203.
51. Igor M, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevskiy B. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia,1996-2001. Antimicrob Agents Chemother 2002, 46:1417-1424. 10.1128/AAC.46.5.1417-1424.2002, 127151, 11959577.
52. Zhang M, Yue J, Yang YP, Zhang HM, Lei JQ, Jin RL, Zhang XL, Wang HH. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J Clin Microbiol 2005, 43:5477-5482. 10.1128/JCM.43.11.5477-5482.2005, 1287806, 16272473.
53. Wengenack NL, Uhl KR, Amand ALS, Tomlinson AJ, Benson LM, Naylor S, Kline BC, Cockerill FR, Rusnak F. Recombinant Mycobacterium tuberculosis KatG (S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. J Infect Dis 1997, 176:722-727. 10.1086/514096, 9291321.
54. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998, 79(1):3-29. 10.1054/tuld.1998.0002, 10645439.
55. Ramaswamy SV, Reich R, Dou SJ, Jasperse L, Pan X, Wanger A, Quitugua T, Graviss EA. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003, 47(4):1241-50. 10.1128/AAC.47.4.1241-1250.2003, 152487, 12654653.
56. Valim A, Rossetti MLR, Ribeiro MO, Zaha A. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis strains from Brazil. J Clin Microbiol 2000, 38:3119-3122. 87207, 10921994.
57. Gingeras TR, Ghandour G, Wang E, Berno A, Small PM, Drobniewski F, Alland D, Desmond E, Holodniy M, Drenkow J. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res 1998, 8:435-448. 58.
58. Siddiqi N, Shamim M, Hussain S, Choudhary R, Ahmed N, Banerjee P, Savithri RG, Alam M, Pathak N, Amin A, Hanief M, Katoch MV, Sharma KS, Hasnain SE. Molecular characterization of multidrug-resistant strains of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 2002, 46:443-450. 10.1128/AAC.46.2.443-450.2002, 127030, 11796356.
59. Heep M, Brandstätter B, Rieger U, Lehn N, Richter E, Rüsch-Gerdes S, Niemann S. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant Mycobacterium tuberculosis clinical strains. J Clin Microbiol 2001, 39:107-110. 10.1128/JCM.39.1.107-110.2001, 87688, 11136757.
60. Yuen L, Leslie D, Coloe PJ. Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains in Australia. J Clin Microbiol 1999, 37:3844-3850. 85826, 10565894.